Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients

PURPOSE: Although dose-dense (dd) chemotherapy plays a fundamental role in the treatment of breast cancer (BC), a variety of trials have presented divergent survival results. Here, we present data of patients with more than 3 positive axillary lymph nodes (+aLN) receiving dd chemotherapy after a med...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Care (Basel)
Main Authors: Reinisch, Mattea, Gluz, Oleg, Ataseven, Beyhan, Blohmer, Jens-Uwe, Budner, Marek, Dittmer-Grabowski, Christine, Kohls, Andreas, Krocker, Jutta, Kümmel, Aylin, Hagemann, Friederike, Rüland, Anna, Traut, Alexander, Kümmel, Sherko
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6600045/
https://ncbi.nlm.nih.gov/pubmed/31316314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491792
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados